At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- BWI Medical Device (device), Varipulse Catheter (device), Dual Energy THERMOCOOL SMARTTOUCH SF Catheter (device)
- How long the study runs
- Study runs about 202 months (dates as stated)
- About the drug or intervention
- BWI Medical Device — device: Participants will be treated with commercially approved BWI medical devices following routine clinical practice. · Varipulse Catheter — device: Participants treated with Varipulse Catheter in the main study will be part of the VARIPURE sub-study. · Dual Energy THERMOCOOL SMARTTOUCH SF Catheter — device: Participants treated with the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter in the main study will be part of the DUACURE sub-study.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 8,000
- Started
- 2021-02-22
- Last checked
- 2026-09
Plain English Summary
What is this study?
- • Testing a new treatment for arrhythmias, cardiac
- • Clinical study - 8,000 participants
- • The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc
Who can take part?
- • Adults
- • Diagnosed with arrhythmias, cardiac
Where?
- • Leicester - Glenfield Hospital
- • London - St. Bartholomew's Hospital
- • London - St George's Hospital
- • London - Royal Brompton Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) medical devices. Data generated from the study will be used to confirm safety and performance of BWI medical devices in the marketed phase and to expand the body of evidence on the use of these devices and techniques in treatment of cardiac arrhythmias.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
Who cannot take part
- ✗Currently participating in an interventional (drug, device, biologic) clinical trial
- ✗Life expectancy of less than 12-months
- ✗Presenting any safety concern for the use of BWI commercially approved medical devices, as indicated in the...
See the full criteria
Where Is This Study? (4 UK sites)
Glenfield Hospital
Leicester LE3 9QP, United Kingdom
St. Bartholomew's Hospital
London EC1A 7BE, United Kingdom
St George's Hospital
London SW17 0QT, United Kingdom
Royal Brompton Hospital
London SW3 6NP, United Kingdom
How to Get in Touch
Nathalie Macours
Sponsor contactCONTACT
Liesbeth Gorissen
Sponsor contactCONTACT
